Nippon Shinyaku Co Ltd ADR(NPPNY)
USD --+0.00%
Reward67High
Risk16Low
📊75%Data
Strong 18% profit margin · 2.5% dividend yield · Revenue growing 13% YoY
NPPNY
+0.0 · +0.00%
USD · PINK
Nippon Shinyaku Co Ltd ADR | Healthcare
Quality Compounder
Market Cap:2.58Bn
ℹ️
Reward Rating
67
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
16
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NPPNY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Nippon Shinyaku Co Ltd ADR?

manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

NPPNY · Verdict

Solid reward · low risk

NPPNY scores well on balance sheet and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

NPPNY · Verdict

What’s working & what to watch

Strengths 6

  • Balance sheet92/100

    Interest covered 244.5×

  • Cash flow89/100

    20% free-cash-flow margin

  • Valuation83/100

    P/E 22.2×

  • Profitability79/100

    20% net margin · 11% ROE

  • Volatility75/100

    Above average

  • Growth67/100

    Rev +5.2% CAGR · earnings +9.2%

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Nippon Shinyaku Co Ltd ADR?

manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.58B, and a P/E ratio of 10.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: High (67)

The scoring profile indicates moderate reward potential, with valuation and profitability as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.58B
P/E Ratio10.9221
Dividend Yield2.46%
52 Week High15.21
52 Week Low5.0275
Last AnnualMarch
IPO DateN/A
IncorporatedUSA
Shares Outstanding270M
No. of Employees2,243
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta-0.328
CurrencyUSD · Reports in JPY